QR052107B Tablets in Patients With Subacute Cough of Phase Ⅱ Study

NCT06920836 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Cough

Interventions

DRUG: QR052107B 100 mg
DRUG: QR052107B 400 mg
DRUG: Placebo

Sponsor

Wuhan Createrna Science and Technology Co., Ltd